🎉 M&A multiples are live!
Check it out!

Adicet Bio Valuation Multiples

Discover revenue and EBITDA valuation multiples for Adicet Bio and similar public comparables like Vivoryon Therapeutics, Pharming, and Benevolent AI.

Adicet Bio Overview

About Adicet Bio

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.


Founded

2014

HQ

United States of America
Employees

152

Website

adicetbio.com

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

-$112M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Adicet Bio Financials

Adicet Bio has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Adicet Bio achieved revenue of n/a and an EBITDA of -$111M.

Adicet Bio expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Adicet Bio valuation multiples based on analyst estimates

Adicet Bio P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue n/a n/a XXX XXX XXX
Gross Profit n/a n/a XXX XXX XXX
Gross Margin NaN% NaN% XXX XXX XXX
EBITDA -$137M -$111M XXX XXX XXX
EBITDA Margin -Infinity% -Infinity% XXX XXX XXX
Net Profit -$69.8M -$143M XXX XXX XXX
Net Margin -Infinity% -Infinity% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Adicet Bio Stock Performance

As of April 15, 2025, Adicet Bio's stock price is $1.

Adicet Bio has current market cap of $46.8M, and EV of -$112M.

See Adicet Bio trading valuation data

Adicet Bio Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
-$112M $46.8M XXX XXX XXX XXX $-1.39

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Adicet Bio Valuation Multiples

As of April 15, 2025, Adicet Bio has market cap of $46.8M and EV of -$112M.

Adicet Bio's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Adicet Bio's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Adicet Bio and 10K+ public comps

Adicet Bio Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV -$112M XXX XXX XXX
EV/Revenue n/a XXX XXX XXX
EV/EBITDA 1.0x XXX XXX XXX
P/E -0.4x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF 1.2x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Adicet Bio Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Adicet Bio Valuation Multiples

Adicet Bio's NTM/LTM revenue growth is n/a

Adicet Bio's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged $0.8M for the same period.

Over next 12 months, Adicet Bio's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Adicet Bio's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Adicet Bio and other 10K+ public comps

Adicet Bio Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth n/a XXX XXX XXX XXX
EBITDA Margin n/a XXX XXX XXX XXX
EBITDA Growth -19% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee n/a XXX XXX XXX XXX
Opex per Employee $0.8M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue n/a XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Adicet Bio Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics and Vaccines & Immunotherapies comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Adicet Bio M&A and Investment Activity

Adicet Bio acquired  XXX companies to date.

Last acquisition by Adicet Bio was  XXXXXXXX, XXXXX XXXXX XXXXXX . Adicet Bio acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Adicet Bio

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Adicet Bio

When was Adicet Bio founded? Adicet Bio was founded in 2014.
Where is Adicet Bio headquartered? Adicet Bio is headquartered in United States of America.
How many employees does Adicet Bio have? As of today, Adicet Bio has 152 employees.
Who is the CEO of Adicet Bio? Adicet Bio's CEO is Mr. Chen Schor, M.B.A..
Is Adicet Bio publicy listed? Yes, Adicet Bio is a public company listed on NAS.
What is the stock symbol of Adicet Bio? Adicet Bio trades under ACET ticker.
When did Adicet Bio go public? Adicet Bio went public in 2020.
Who are competitors of Adicet Bio? Similar companies to Adicet Bio include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Adicet Bio? Adicet Bio's current market cap is $46.8M
Is Adicet Bio profitable? Yes, Adicet Bio is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.